In the future, molecular therapies may be more precise and related to fewer side effects.
New medicines are currently undergoing Phase III clinical trials, and should be available on the market in two years' time. They use a number of molecules which have the specific effect of inhibiting T lymphocytes. The aim of these medicines is to reduce the amount of eruptions of psoriasis.
If it would be possible to take control over these molecules it may be possible to clear psoriatic plaques.
We have seen that psoriasis is perpetuated by disturbances to the skin's immune functions. Existing medicines inhibit cutaneous immune reactions, but these all have side effects.
Researchers are therefore concentrating on molecules which will be more effective and better tolerated.
Also, research is underway to improve immunosuppressants which can be administered locally and therefore may be better tolerated.
Find information about available medication via this link.
Medication can be something to apply on the skin, something to swallow or something to be injected.